On September 11, 1989, Mr. Roy Vagelos transferred the world’s most advanced hepatitis B vaccine production patent to China at a final transaction price of US$7 million. At that time, hepatitis B was very important to our country. For example, it was the second largest fatal disease at that time, and the price was US$7 million, which was an ideal price that our country could accept at the time.